Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Peter Hiatt"'
Autor:
LH Cameron, Charles A. Peloquin, JC McNeil, A Patel, Jeffrey R. Starke, F Ruiz, Michael Mann, J Faircloth, Peter Hiatt
Publikováno v:
Journal of Cystic Fibrosis. 21:348-352
Few studies have evaluated clofazimine (CLOF) drug monitoring and safety in children. We treated 10 children, 8 with CF, for NTM infection with multiple antimicrobials, including CLOF. All had serial blood CLOF concentrations measured and were follow
Autor:
Margaret Rosenfeld, Claire E Wainwright, Mark Higgins, Linda T Wang, Charlotte McKee, Daniel Campbell, Simon Tian, Jennifer Schneider, Steve Cunningham, Jane C Davies, Claire E. Wainwright, Linda T. Wang, Jane C. Davies, William Harris, Peter Mogayzel, Karen McCoy, Carlos Milla, Ronald Rubenstein, Seth Walker, Philip Black, Gregory Montgomery, Susanna McColley, Peter Hiatt, Gregory Sawicki, Michael Rock, Paul Aurora, Felix Ratjen, Anirban Maitra, Andrew Ives, Erol Gaillard, Paul McNalley, Hiranjan Selvadurai, Philip Robinson
BACKGROUND: Ivacaftor is generally safe and effective in patients aged 2 years and older who have cystic fibrosis and specific CFTR mutations. We assessed its use in children aged 12 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4580b2c0db6f069b4dcb6d8915055da8
http://hdl.handle.net/10044/1/60167
http://hdl.handle.net/10044/1/60167
Autor:
Philip M. Farrell, James D. Acton, Margaret Rosenfeld, Peter J. Mogayzel, Carol Conrad, Peter Hiatt, Lyndia C. Brumback, Margaret Kloster, Robert G. Castile, Thuy L. Vu, Andrew A. Colin, Gwendolyn S. Kerby, Meeghan A. Hart, Jonathan O. Swanson, Stephanie D. Davis, Robin Johnson
Publikováno v:
European Respiratory Journal. 42:1545-1552
The optimal strategy for monitoring cystic fibrosis lung disease in infancy remains unclear. Our objective was to describe longitudinal associations between infant pulmonary function tests, chest radiograph scores and other characteristics. Cystic fi
Autor:
Robin Johnson, Gwendolyn S. Kerby, Meeghan A. Hart, Lyndia C. Brumback, Robert G. Castile, Margaret Kloster, Peter Hiatt, Margaret Rosenfeld, Stephanie D. Davis
Publikováno v:
European Respiratory Journal. 41:60-66
This study aimed to describe lung function in a cohort of children with cystic fibrosis (CF) who underwent infant pulmonary function tests (IPFTs) and preschool spirometry. Children performed up to four IPFTs (raised volume rapid thoracic compression
Autor:
Clement L. Ren, Paul Jones, Gwendolyn S. Kerby, Stephanie D. Davis, Margaret Kloster, Meeghan A. Hart, Oscar H. Mayer, Robin Johnson, Peter Hiatt, Margaret Rosenfeld, Lyndia C. Brumback, Robert G. Castile
Publikováno v:
Pediatric Pulmonology. 47:574-581
Objective To analyze cross-sectional and longitudinal associations between lung function measures and clinical features in a cohort of preschool children with cystic fibrosis (CF). Methods Longitudinal eight-center observational study of children wit
Autor:
Lyndia C. Brumback, Robert G. Castile, Margaret Kloster, Meeghan A. Hart, Margaret Rosenfeld, Peter J. Mogayzel, Gwendolyn S. Kerby, Carol Conrad, Andrew A. Colin, Stephanie L. Wilcox, Robin Johnson, James D. Acton, Peter Hiatt, Stephanie D. Davis
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 182:1387-1397
The conducting of clinical trials in infants with cystic fibrosis (CF) has been hindered by lack of sensitive outcome measures.To evaluate safety, feasibility, and ability to detect abnormalities in lung function of serial pulmonary function tests (P
Autor:
Shauna L. Schoonover, Alan M. Jewell, Stanley G. Cron, Pedro A. Piedra, Susan Grace, Christopher M. Oermann, Daniel F. Garcia, Mark W. Riggs, Peter Hiatt
Publikováno v:
Pediatric Pulmonology. 42:66-74
Background: Human metapneumovirus (hMPV) has been isolated from children with acute respiratory infection worldwide. Its epidemiology remains to be defined in children with cystic fibrosis (CF). We describe the epidemiology and clinical impact of hMP
Autor:
Suzanne Steinbach, Robert B. Mellins, Mary Ellen B. Wohl, Michael D. Weisner, Andrew Ting, Meyer Kattan, J. Sunil Rao, Peter Hiatt, Hannah Peavy, Andrew A. Colin, Mark D. Schluchter, Arnold C. G. Platzker, Kevin McCarthy, Xin C. Chen, Kirk A. Easley, Anastassios C. Koumbourlis
Publikováno v:
Pediatric Pulmonology. 37:318-323
We compared three methods of reporting maximal expiratory flow (V'maxFRC) measured in partial expiratory flow-volume curves (PEFVCs) at the point of functional residual capacity (FRC). PEFVCs were obtained with the rapid thoracoabdominal compression
Publikováno v:
Pediatric Allergy, Immunology, and Pulmonology. 25:231-233
Ivacaftor is a small-molecule potentiator of the cystic fibrosis (CF) transmembrane-conductance regulator and was recently approved for use in CF patients with at least one copy of the G551D mutation. Two clinical trials have proven its efficacy in C
Autor:
Robert K. Ernst, David A. D′Argenio, Maynard V. Olson, Bonnie W. Ramsey, David H. Spencer, Gita Bangera, Jane L. Burns, Arnold Kas, Sara E. Selgrade, Mitchell J. Brittnacher, Jeffrey K. Ichikawa, Stephen Lory, Karen McCoy, Peter Hiatt, Samuel I. Miller
Publikováno v:
Environmental Microbiology. 5:1341-1349
Pseudomonas aeruginosa strains from the chronic lung infections of cystic fibrosis (CF) patients are phenotypically and genotypically diverse. Using strain PAO1 whole genome DNA microarrays, we assessed the genomic variation in P. aeruginosa strains